Gulf Pharmaceutical Industries - Julphar announced the signing of a landmark agreement with Sunshine Lake Pharma to pioneer insulin Biosimilar Manufacturing in MENA.

Gulf Pharmaceutical Industries - Julphar announced the signing of a landmark agreement with Sunshine Lake Pharma to pioneer insulin Biosimilar Manufacturing in MENA. This strategic partnership is aligned with the Ministry of Industry and Advanced Technology’s (MoIAT) vision including the National Strategy for Industry and Advanced Technology and In-Country Value Program (ICV).

For more details: https://www.julphar.net/en/gulf-pharmaceutical-industries--julphar--signs-landmark-agreement-with-sunshine-lake-pharma-to-pioneer-insulin-biosimilar-manufacturing-in-mena-2